(Q44602608)

4 December 2017

title

Adverse endometrial effects during long cycle hormone replacement therapy. Scandinavian Long Cycle Study Group (English)

1 reference

4 December 2017

Bjarnason K

1

1 reference

4 December 2017

Cerin A

series ordinal

2

1 reference

4 December 2017

Lindgren R

series ordinal

3

1 reference

4 December 2017

Weber T

series ordinal

4

1 reference

4 December 2017

publication date

1 August 1999

1 reference

4 December 2017

1 reference

4 December 2017

volume

32

1 reference

4 December 2017

issue

3

1 reference

4 December 2017

page(s)

161-170

1 reference

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900033-X

7 January 2021

HRT: developments in therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900033-X

7 January 2021

The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900033-X

7 January 2021

Compliance with hormonal replacement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900033-X

7 January 2021

Cyclical mood changes as in the Premenstrual tension Syndrome during Sequential Estrogen-Progestagen Postmenopausal Replacement Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900033-X

7 January 2021

Transdermal hormonal replacement therapy with transdermal progestin every second month

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900033-X

7 January 2021

Can progestin be limited to every third month only in postmenopausal women taking estrogen?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900033-X

7 January 2021

Endometrial response in estrogen replacement therapy quarterly combined with a progestogen

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900033-X

7 January 2021

Effects of Estrogens and Progestins on the Biochemistry and Morphology of the Postmenopausal Endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900033-X

7 January 2021

Prevention of endometrial hyperplasia by progesterone during long-term estradiol replacement: influence of bleeding pattern and secretory changes.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900033-X

7 January 2021

Endometrial Histology and Biochemistry in Climacteric Women during Oestrogen and Oestrogen/Progestogen Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900033-X

7 January 2021

Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900033-X

7 January 2021

Endometrial morphology in asymptomatic postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900033-X

7 January 2021

Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900033-X

7 January 2021

Monitoring of oestrogen replacement therapy by vaginosonography of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900033-X

7 January 2021

Endometrial response in sequential cyclic therapy assessed with associated hysteroscopy and histology

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900033-X

7 January 2021

Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900033-X

7 January 2021

Hormone replacement therapy and endometrial cancer risk: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900033-X

7 January 2021

Nucleolar organizer regions as markers of endometrial proliferation: a study of normal, hyperplastic, and neoplastic tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900033-X

7 January 2021

Amplification and expression of the c-erbB-2 oncogene in normal, hyperplastic, and malignant endometria

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900033-X

7 January 2021

A simple method for determining the optimal dosage of progestin in postmenopausal women receiving estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900033-X

7 January 2021

Is the timing of withdrawal bleeding a guide to endometrial safety during sequential oestrogen-progestagen replacement therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900033-X

7 January 2021

10.1016/S0378-5122(99)00033-X

Identifiers

DOI

1 reference

4 December 2017

1 reference